• LAST PRICE
    12.6200
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    5.0400/ 2
  • Ask / Lots
    14.5000/ 3
  • Open / Previous Close
    12.9000 / 12.6200
  • Day Range
    Low 12.6200
    High 13.1400
  • 52 Week Range
    Low 6.2600
    High 14.5000
  • Volume
    3,564
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 12.53
TimeVolumeOCS
09:48 ET10012.9
09:50 ET16512.85
10:27 ET10012.875
10:42 ET57013.14
01:13 ET10012.75
02:57 ET10012.67
03:15 ET20012.78
03:53 ET10012.74
04:00 ET23712.62
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesOCS
Oculis Holding AG
455.9M
0.0x
---
United StatesLIAN
LianBio
519.8M
-5.9x
---
United StatesNKTX
Nkarta Inc
507.4M
-4.6x
---
United StatesREPL
Replimune Group Inc
528.5M
-2.8x
---
United StatesSTTK
Shattuck Labs Inc
483.3M
-4.3x
---
United StatesIVVD
Invivyd Inc
477.9M
-2.8x
---
As of 2024-02-28

Company Information

Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Contact Information

Headquarters
Bahnhofstrasse 7ZUG, ZUG, Switzerland 6300
Phone
---
Fax
---

Executives

Independent Chairman of the Board
Anthony Rosenberg
Chief Executive Officer, Director
Riad Sherif
Chief Financial Officer
Sylvia Cheung
Head - Medical Affairs
Joanne Chang
Head - Development
Bastian Dehmel

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$455.9M
Revenue (TTM)
---
Shares Outstanding
36.4M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
---
Book Value
$-3.40
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.